Journal Article Summary
The article investigates the effects of proton pump inhibitors (PPIs) on intestinal epithelial permeability, a topic of growing concern due to the widespread use of these medications for conditions like gastroesophageal reflux disease and peptic ulcers. While PPIs are effective in reducing stomach acid, they have been linked to various adverse effects, including potential damage to the intestinal barrier. Understanding how PPIs impact intestinal permeability is crucial, as this can lead to increased susceptibility to gastrointestinal disorders and infections.
In the study, researchers administered different doses of pantoprazole sodium, a type of PPI, to male mice and cultured human intestinal cells to assess changes in intestinal permeability. They measured the expression of occludin, a protein essential for maintaining tight junctions between intestinal cells, and found that PPI treatment significantly reduced occludin levels, leading to increased permeability. The study also revealed that the p38-MAPK/NF-κB signaling pathway was activated by PPI treatment, which contributed to the observed changes in permeability.
Despite the findings, the study has limitations, including the method of administering PPIs via injection rather than the oral route typically used in clinical settings. This difference may affect how the drug interacts with the intestinal barrier and its overall impact. Patients and caregivers should discuss these findings with healthcare professionals, especially if they are using PPIs, to weigh the benefits against potential risks, particularly for those with pre-existing gastrointestinal conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Zhang Meng, Liu Wei, Liu Yunhui, Cheng Qiuyu, Zhang Xiaolei, Qian Na, Qi Junying, Chen Tao, et al.. Proton pump inhibitor increases intestinal epithelial paracellular permeability via the p38-MAPK/NF-κB signaling pathway. Molecular Biology Reports 2025. DOI: 10.1007/s11033-025-11336-y. PMID: 41369838. PMCID: PMC12696144.
Featured Pill Pals Product
Pantoprazole 20 mg Enteric Coated Tablets --- Generic For Protonix
Pantoprazole 20 mg Enteric Coated Tablets — Generic For Protonix is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
